3-Methoxymethamphetamine
| Clinical data | |
|---|---|
| Other names | 3-Methoxy-N-methylamphetamine; meta-Methoxymethamphetamine; meta-Methoxy-N-methylamphetamine; MMMA; 3-MeO-MA; 3-MMA |
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO |
| Molar mass | 179.263 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
3-Methoxymethamphetamine, (3-MMA), also known as meta-methoxymethamphetamine (MMMA), is a psychoactive drug of the amphetamine family related to 3-methoxyamphetamine (3-MA or MMA) and to positional isomers like ortho-methoxymethamphetamine (OMMA) and para-methoxymethamphetamine (PMMA).[1] It has been said that virtually nothing is known about the activity of 3-MMA.[1] In any case, its N-demethylated analogue 3-MA is known to act as a serotonin–norepinephrine–dopamine releasing agent (SNDRA)[2][3][4] and to produce associated effects like PMA-like interoceptive effects and stimulant-like effects in rodents.[5][6][4] Alexander Shulgin has noted that N-methylation of amphetamines generally preserves such activities, in contrast to the case of psychedelic activity.[7] The chemical synthesis of 3-MMA has been described.[8]
See also
[edit]- Substituted methoxyphenethylamine
- para-Methoxyamphetamine (PMA)
- Fenfluramine
- 2-Methoxymethamphetamine (OMMA; methoxyphenamine)
- 3-Chloromethamphetamine
- 3-Methoxy-4-methylamphetamine (MMA)
- 4-Fluoromethamphetamine (4-FMA)
- 4-Methylmethamphetamine (4-MMA)
References
[edit]- 1 2 Dal Cason TA (June 2001). "A re-examination of the mono-methoxy positional ring isomers of amphetamine, methamphetamine and phenyl-2-propanone". Forensic Science International. 119 (2): 168–194. doi:10.1016/S0379-0738(00)00425-4. PMID 11376983.
Virtually nothing has been reported about the activity of the 3-methoxymethamphetamine (m-methoxymethamphetamine, MMMA) isomer of PMMA.
- ↑ Blough B (July 2008). "Dopamine-releasing agents" (PDF). In Trudell ML, Izenwasser S (eds.). Dopamine Transporters: Chemistry, Biology and Pharmacology. Hoboken [NJ]: Wiley. pp. 305–320. ISBN 978-0-470-11790-3. OCLC 181862653. OL 18589888W.
- ↑ Tseng LF, Menon MK, Loh HH (May 1976). "Comparative actions of monomethoxyamphetamines on the release and uptake of biogenic amines in brain tissue". The Journal of Pharmacology and Experimental Therapeutics. 197 (2): 263–271. PMID 1271280.
- 1 2 Menon MK, Tseng LF, Loh HH (May 1976). "Pharmacological evidence for the central serotonergic effects of monomethoxyamphetamines". The Journal of Pharmacology and Experimental Therapeutics. 197 (2): 272–279. PMID 946817.
- ↑ Glennon RA, Young R, Hauck AE (May 1985). "Structure-activity studies on methoxy-substituted phenylisopropylamines using drug discrimination methodology". Pharmacology, Biochemistry, and Behavior. 22 (5): 723–729. doi:10.1016/0091-3057(85)90520-9. PMID 3839309. S2CID 22341227.
- ↑ Loh HH, Tseng LF (1978). "Role of biogenic amines in the actions of monomethoxyamphetamines". In Stillman RC, Willette RE (eds.). The Psychopharmacology of Hallucinogens. Pergamon. pp. 13–22. ISBN 978-1-4831-4606-5. Retrieved 16 January 2025.
- ↑ Shulgin A, Shulgin A (September 1991). PiHKAL: A Chemical Love Story. Berkeley, California: Transform Press. ISBN 0-9630096-0-5. OCLC 25627628.
- ↑ Shulgin A, Manning T, Daley PF (2011). The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley: Transform Press. ISBN 978-0-9630096-3-0.